Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Commerzbank to cut 3,900 jobs, lift targets in bid to fend off UniCredit

(Sharecast News) - German lender Commerzbank is slashing almost 4,000 jobs and lifting financial targets as it moves to repel takeover moves from Italy's UniCredit. Commerzbank said it would target net profit of €4.2bn, a significant jump from last year's €2.7bn.

"We are accelerating our profitable growth and consistently driving forward our transformation. This makes Commerzbank stronger and better," said chief executive Bettina Orlopp ahead of a capital markets day.

The 3,900 job cuts, or 10% of the workforce, are expected to be implemented by 2028. Commerzbank said the losses would come from "efficiency gains" due to digitalisation, moves to overseas locations with cheaper staff and offering early retirement.

Restructuring costs will come in at around €700m before taxes in 2025, the bank added.

UniCredit now has a 28% percent stake in its rival. CEO Andrea Orcel is waiting until after German general election on February 23 before deciding on whether to launch a bid.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.